These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia. Ford CD, Asch J, Pulsipher M, Petersen FB. Br J Haematol; 2004 Aug; 126(4):623-4. PubMed ID: 15287959 [No Abstract] [Full Text] [Related]
6. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Tosti S, Caruso R, D'Adamo F, Picardi A, Ali Ege M, Girelli G, Mauro FR, Maurillo L, Amadori S. Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584 [No Abstract] [Full Text] [Related]
17. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma. Vick DJ, Byrd JC, Beal CL, Chaffin DJ. Vox Sang; 1998 Jan; 74(2):122-6. PubMed ID: 9501412 [Abstract] [Full Text] [Related]
18. Evan's syndrome precipitated by fludarabine therapy in a case of CLL. Sen K, Kalaycio M. Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320 [No Abstract] [Full Text] [Related]
19. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia]. Antich Rojas J, Balaguer H, Cladera A. Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277 [No Abstract] [Full Text] [Related]